Cargando…

Characteristics of patients with venous thromboembolism and atrial fibrillation in Venezuela

BACKGROUND: Studies describing venous thromboembolic event (VTEE) and atrial fibrillation (AF) in South American populations are limited. The aim of this cross-sectional study was to describe the characteristics of Venezuelan patients admitted and treated for these conditions. METHODS: A retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennett, Dimitri, Abate, Jorge, Abrahamson, Page E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121639/ https://www.ncbi.nlm.nih.gov/pubmed/21627817 http://dx.doi.org/10.1186/1471-2458-11-415

Ejemplares similares

Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
por: Lin, Yu-Sheng, et al.
Publicado: (2021)

Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2014)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

Left Atrial Remodeling and Thromboembolic Risk in Patients With Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2022)

Atrial Fibrillation and Cryptogenic Thromboembolic Events
por: Henz, Benhur Davi, et al.
Publicado: (2018)

Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide
por: De Caterina, Raffaele, et al.
Publicado: (2017)

Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism
por: Stacy, Zachary A., et al.
Publicado: (2016)

Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism Patients
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
por: Ballestri, Stefano, et al.
Publicado: (2022)

Left Atrial Diameter in the Prediction of Thromboembolic Event and Death in Atrial Fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review
por: Mearns, Elizabeth S, et al.
Publicado: (2014)

Left Atrial Dysfunction, Fibrosis and the Risk of Thromboembolism in Patients With Paroxysmal and Persistent Atrial Fibrillation
por: Kim, Hee-Dong, et al.
Publicado: (2022)

Characteristics and Prognostic Factors of Venous Thromboembolism in Cancer Patients
por: Tsuyuki, Hajime, et al.
Publicado: (2022)

Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
por: Wang, Ying, et al.
Publicado: (2019)

Thromboembolism in renal transplant artery due to atrial fibrillation
por: Müller-Deile, Janina, et al.
Publicado: (2013)

Two Cases of Multiple Thromboembolism With Asymptomatic Atrial Fibrillation
por: Tanaka, Yudai, et al.
Publicado: (2022)

Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation
por: Matos, Jason D., et al.
Publicado: (2018)

In-hospital direct costs for thromboembolism and bleeding in Chinese patients with atrial fibrillation
por: Chang, San-Shuai, et al.
Publicado: (2018)

Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study
por: Balsam, Paweł, et al.
Publicado: (2018)

Atrial fibrillation and atrial tachycardia in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy
por: Havranek, Stepan, et al.
Publicado: (2020)

Studies on Atrial Fibrillation and Venous Thromboembolism in the Past 20 Years: A Bibliometric Analysis Via CiteSpace and VOSviewer
por: Miao, Lina, et al.
Publicado: (2023)

Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2020)

Impact of age on thromboembolic events in patients with non‐valvular atrial fibrillation
por: Kim, Yun Gi, et al.
Publicado: (2019)

Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation
por: Cartledge, Richard, et al.
Publicado: (2021)

A retrospective study of real-world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia
por: Alosaimi, Hind M., et al.
Publicado: (2022)

Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF study: Erratum
Publicado: (2019)

Elevated plasma Ninjurin-1 levels in atrial fibrillation is associated with atrial remodeling and thromboembolic risk
por: Fang, Chen, et al.
Publicado: (2022)

Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation
por: Pezzo, Mario Piergiulio, et al.
Publicado: (2022)

Transesophageal echocardiographic thromboembolic risk is associated with smoking status in patients with atrial fibrillation
por: Inao, Kyoko, et al.
Publicado: (2017)

Risk of Thromboembolism in Non-Valvular Atrial Fibrillation With or Without Clinical Hyperthyroidism
por: Lin, Yu-Sheng, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism
por: Ruiz-Artacho, Pedro, et al.
Publicado: (2018)

Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients
por: Hallinen, Taru, et al.
Publicado: (2016)

Addition of aspirin to venous thromboembolism chemoprophylaxis safely decreases venous thromboembolism rates in trauma patients
por: Lammers, Daniel, et al.
Publicado: (2023)

Effect of ovarian tumor characteristics on venous thromboembolic risk
por: Bakhru, Arvind
Publicado: (2013)

Thromboembolism and Major Bleeding in Patients with Atrial Fibrillation and EHRA Type 2 Valvular Heart Disease: The Jordan Atrial Fibrillation (JoFib) Study
por: Al-Najar, Mahasen, et al.
Publicado: (2023)

Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis
por: Costa, Olivia S., et al.
Publicado: (2020)

Venezuela: out of the headlines but still in crisis
por: Doocy, Shannon, et al.
Publicado: (2022)

Venezuela
Publicado: (1969)

Venezuela
por: Martínez Amengual, Gumersindo
Publicado: (1967)

Venezuela
por: Cunill, Pedro
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_jf8im24mmlr6j746rbi0ie3hh8